Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Автори: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Frontiers Media
2021
|
Схожі ресурси
Схожі ресурси
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
за авторством: Helen L. Stark, та інші
Опубліковано: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
за авторством: Alzhrani, AI
Опубліковано: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
за авторством: Honeyman, C, та інші
Опубліковано: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
за авторством: Honeyman, C, та інші
Опубліковано: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
за авторством: Maja-Theresa Dieterlen, та інші
Опубліковано: (2021-08-01)